Pharmacologic Response and Safety of Inhaled Insulin in Type 1 Diabetes

Phase 1/2 Completed 12 enrolled Dance Biopharm Inc.

RandomizedCrossoverOpen-label

Summary

The purpose of this study was to compare the pharmacokinetic (PK) response after inhaled insulin administration with 3 different inhalation regimens and with subcutaneous insulin administration.

Timeline

Start: 2013-05
Primary completion: 2013-07
Completion: 2013-07

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Insulin	Protein / enzyme biologic	50 iu	Inhaled
Comparator	Insulin Lispro	Protein / enzyme biologic	6 iu	Subcutaneous

Pharmacologic Response and Safety of Inhaled Insulin in Type 1 Diabetes

Summary

Timeline

Drugs

Indications